AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...

If you are wondering whether AstraZeneca shares are offering fair value at current levels, this breakdown will help you connect the recent share price with what the underlying business might justify.

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the ...

The Board of AstraZeneca plc (NASDAQ: AZN) is recommending to shareholders a Harmonized Listing Structure for the company's ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm ...

AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. Pfizer CEO Albert Bourla appeared with ...

How AstraZeneca’s recent performance may look to long term holders AstraZeneca (LSE:AZN) shares have moved mixed recently, with a 2.7% decline over the past day, a small gain over the past week, a 1.7 ...

The pharmaceutical giant is plowing billions of dollars into expanding its drug-making capacity. It has ambitious plans for two facilities in Maryland. 10 stocks we like better than AstraZeneca Plc › ...

Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...